Randomised Controlled TrialtaVNSn = 50

Efficacy and safety of transcutaneous auricular vagus nerve stimulation for patients with treatment-resistant schizophrenia with predominantly negative symptoms: a randomized clinical trial and efficacy sensitivity biomarkers

Cui Y, Sun J, Zhang B, Guo T, Zhang S, Li Z, Chen Y, Su M, Wu D, Wu J, et al.

Molecular Psychiatry · 2025

Key finding

In the intention-to-treat analysis, patients receiving active taVNS showed a significantly greater improvement in negative symptoms compared with those receiving the sham procedure (PANSS-FSNS difference, -1.36; effect size, -0.62; 95% CI, -1.20 to -0.04; p = 0.033), with effects sustained at fol...

Condition
Schizophrenia
Stimulation
taVNS
Evidence tier
Randomised Controlled Trial
Participants
50
View on DOI

Cite this study

Cui, Y., Sun, J., Zhang, B., Guo, T., Zhang, S., Li, Z., Chen, Y., Su, M., Wu, D., Wu, J., Wang, Q., Yuan, Y., Wang, J., Tian, Q., He, F., Wu, L., Li, X., Gong, Y., & Qin, W. (2025). Efficacy and safety of transcutaneous auricular vagus nerve stimulation for patients with treatment-resistant schizophrenia with predominantly negative symptoms: a randomized clinical trial and efficacy sensitivity biomarkers. Molecular Psychiatry, 30(11), 5437-5447. https://doi.org/10.1038/s41380-025-03132-8

Related studies in Schizophrenia

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.